A qualitative exploration of how pharmacy professionals in primary care utilise planned protected development time

IF 1.8 Q3 PHARMACOLOGY & PHARMACY Exploratory research in clinical and social pharmacy Pub Date : 2024-02-01 DOI:10.1016/j.rcsop.2024.100417
Fiona Cairns , Robyn Patrick , Gillian Calderhead , Paul Forsyth , Gazala Akram
{"title":"A qualitative exploration of how pharmacy professionals in primary care utilise planned protected development time","authors":"Fiona Cairns ,&nbsp;Robyn Patrick ,&nbsp;Gillian Calderhead ,&nbsp;Paul Forsyth ,&nbsp;Gazala Akram","doi":"10.1016/j.rcsop.2024.100417","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>With patients developing more complex healthcare and medicine needs, it is imperative pharmacy professionals enhance their knowledge and skills to enable an advanced level of pharmaceutical practice, improving service provision and supporting patient care. The UK Royal Pharmaceutical Society (RPS) is urging employers to incorporate protected time within the working week to facilitate this development. Currently protected development time (PDT) is not well established within the pharmacy profession and there is little qualitative data available about the utility of this.</p></div><div><h3>Objective</h3><p>To explore how pharmacy professionals in primary care currently utilise planned protected ‘development time’ and their perception of this.</p></div><div><h3>Methods</h3><p>One-to-one semi-structured interviews were conducted between February and March 2023 via Microsoft Teams® with pharmacists, pharmacy technicians (PTs) and pharmacy support workers (PSWs), working in a large Health board area in Scotland who had established PDT since August 2021. Interview recordings were transcribed verbatim and analysed using an inductive thematic framework approach.</p></div><div><h3>Results</h3><p>Interviews were conducted with 13 participants (12 female); 6 pharmacists, 5 PTs and 2 PSWs. Five core themes were derived from the data: logistics, competing priorities, methods for development, inequalities and benefits. Participants utility of PDT was variable, most focused on self-development to improve clinical knowledge however, supporting the development of others often taking precedence. Disparities in utility and inequity of protection from service delivery were highlighted. All participants befitted from PDT reporting a self-assessed improvement in confidence and competence.</p></div><div><h3>Conclusion</h3><p>The experience of participants who had PDT was typically perceived as positive including supporting development and improving wellbeing however, it fostered inequalities which needs addressing. Educational input is required to provide direction for development across all four pillars of professional practice; clinical practice, leadership, education and research, promoting advanced practice. Further research is required to assess the impact of PDT on health outcomes of the local population.</p></div>","PeriodicalId":73003,"journal":{"name":"Exploratory research in clinical and social pharmacy","volume":null,"pages":null},"PeriodicalIF":1.8000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266727662400012X/pdfft?md5=bfaaa3281d1ce9e1f03725ea0b3484c4&pid=1-s2.0-S266727662400012X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploratory research in clinical and social pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S266727662400012X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

With patients developing more complex healthcare and medicine needs, it is imperative pharmacy professionals enhance their knowledge and skills to enable an advanced level of pharmaceutical practice, improving service provision and supporting patient care. The UK Royal Pharmaceutical Society (RPS) is urging employers to incorporate protected time within the working week to facilitate this development. Currently protected development time (PDT) is not well established within the pharmacy profession and there is little qualitative data available about the utility of this.

Objective

To explore how pharmacy professionals in primary care currently utilise planned protected ‘development time’ and their perception of this.

Methods

One-to-one semi-structured interviews were conducted between February and March 2023 via Microsoft Teams® with pharmacists, pharmacy technicians (PTs) and pharmacy support workers (PSWs), working in a large Health board area in Scotland who had established PDT since August 2021. Interview recordings were transcribed verbatim and analysed using an inductive thematic framework approach.

Results

Interviews were conducted with 13 participants (12 female); 6 pharmacists, 5 PTs and 2 PSWs. Five core themes were derived from the data: logistics, competing priorities, methods for development, inequalities and benefits. Participants utility of PDT was variable, most focused on self-development to improve clinical knowledge however, supporting the development of others often taking precedence. Disparities in utility and inequity of protection from service delivery were highlighted. All participants befitted from PDT reporting a self-assessed improvement in confidence and competence.

Conclusion

The experience of participants who had PDT was typically perceived as positive including supporting development and improving wellbeing however, it fostered inequalities which needs addressing. Educational input is required to provide direction for development across all four pillars of professional practice; clinical practice, leadership, education and research, promoting advanced practice. Further research is required to assess the impact of PDT on health outcomes of the local population.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对基层医疗机构药学专业人员如何利用有计划的受保护发展时间的定性探索
背景随着患者对医疗保健和药品的需求日益复杂,药学专业人员必须加强自身的知识和技能,以提高药学实践水平,改善服务提供并支持患者护理。英国皇家药学会(RPS)正在敦促雇主在每周工作时间中加入受保护时间,以促进这一发展。方法 2023 年 2 月至 3 月期间,我们通过 Microsoft Teams® 对在苏格兰一个大型卫生局辖区工作的药剂师、药剂技师 (PT) 和药剂支持工作者 (PSW) 进行了一对一的半结构化访谈,这些药剂师、药剂技师和药剂支持工作者自 2021 年 8 月起开始使用受保护的 "发展时间"。访谈记录被逐字誊写,并采用归纳式主题框架方法进行分析。结果访谈了 13 名参与者(12 名女性),其中包括 6 名药剂师、5 名药房技师和 2 名药房辅助人员。从数据中得出了五个核心主题:物流、相互竞争的优先事项、发展方法、不平等和益处。参加者对 PDT 的效用各不相同,大多数人侧重于自我发展,以提高临床知识,但支持他人的发展往往优先。与会者强调了效用上的差异以及从服务提供中获得保护的不平等。所有参与者都从临床数据处理中获益,报告了自我评估的信心和能力的提高。结论:临床数据处理参与者的经历通常被认为是积极的,包括支持发展和提高福利,但是,它造成了不平等,需要加以解决。需要教育投入为专业实践的所有四大支柱提供发展方向:临床实践、领导力、教育和研究、促进高级实践。需要进一步开展研究,以评估 PDT 对当地人口健康结果的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
0
审稿时长
103 days
期刊最新文献
Montelukast deprescribing in outpatient specialty clinics: A single center cross-sectional study Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation at a tertiary care hospital in Thailand Comparing nursing medication rounds before and after implementation of automated dispensing cabinets: A time and motion study Translation, transcultural adaptation, and validation of the Brazilian Portuguese version of the general medication adherence scale (GMAS) in patients with high blood pressure A cross-sectional survey exploring organizational readiness to implement community pharmacy-based opioid counseling and naloxone services in rural versus urban settings in Alabama
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1